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August 2012582 AbstractsConclusions: Overall, EH for infrainguinal arterial bypass confers no
additional benefit in wound complication or bypass patency rates compared
with OH. However, the possibility that bypass patency may be enhanced by
EH in the nonhemodialysis population deserves further study.
Outpatient Common Femoral Artery Stenting: Midterm Outcomes
Sam S. Ahn, MD, Monica J. Uceda, MD, Kenneth R. Kollmeyer, MD,
Craig A. Ferrara, DO, and Pablo V. Uceda, MD. DFW Vascular Group,
Dallas, Texas
Objective: Stenting of common femoral artery (CFA) lesions is con-
troversial. The purpose of this study was to demonstrate the safety, efficacy,
and midterm outcomes of CFA stenting.
Methods: From January 2009 to December 2011, 61 patients, 29 men
(48%) and 32 women, underwent CFA stenting in our outpatient office angio-
suite. Patients were a mean age of 67.28  9.85 years. The most common
comorbidities were hypertension (91.8%), smoking (59%), hyperlipidemia
(59%), and diabetes (39.34%). Indications for the procedure were moderate
claudication (4.35%), severe claudication (50.72%), ischemic rest pain
(37.68%), and nonhealing ulcer (7.25%). We retrospectively analyzed the out-
comes of 69 CFA lesions by evaluating clinical improvement and patency.
Results: Follow-up for clinical improvement showed 30 patients
(44.12%) achieved the “markedly improved” Rutherford classification,
14 (20.59%) were “moderately improved,” and the condition worsened
in seven (10.29%). The cumulative primary patency rate was 94% at 3
months, 82% at 6 months, 71% at 9 months, and 67% at 12 months,
remaining the same over 24 months. Cumulative primary assisted pa-
tency was 100% at 21 months. Thirteen cases (19%) were considered as
failures. Concomitant vascular stenting in other vessels was performed in
58 patients (83.82%). The only postoperative complication was a groin
hematoma in one patient (1.47%). Twenty stents (29.41%) subsequently
were punctured, without complications, to achieve access for other
endovascular procedures.
Conclusions: Stenting of CFA lesions with self-expandable stents is
safe and effective in the outpatient office setting. Puncturing the CFA stent
for subsequent endovascular access is also safe and effective.
Clinical Consequence of Bare-Metal Stent and Stent Graft Failure in
Femoropopliteal Occlusive Disease
Shant M. Vartanian,1 Paul J. Johnston,2 Joy P. Walker,1 Sara J. Runge,1
Charles M. Eichler,1 and Michael S. Conte1. 1University of California–San
Francisco, San Francisco, Calif; and 2Colorado Permanente Medical Group,
Denver, Colo
Objective: The optimal role for bare-metal stents (BMS) and stent
grafts (SG) in treating femoropopliteal occlusive disease (FPOD) is as yet
undefined. Understanding the clinical consequences of failure can help
guide initial treatment decisions. The goal of this study was to define the
nature and frequency of adverse clinical events related to BMS and SG failure
in FPOD.
Methods: This is a single-institution retrospective review of the pri-
Fig.mary endovascular intervention for FPOD, treated with BMS or SG, from
September 2007 through October 2011. Patient demographics, indications
(
ror intervention, anatomic characteristics, procedural details, clinical outcomes,
nd reintervention details were reviewed. Patients were excluded if they had any
revious lower extremity interventions or inadequate follow-up.
Results: Of the 127 limbs from 97 patients that met the inclusion
riteria, 67 were treated with BMS and 60 with SG. Follow-up averaged 551
ays for BMS and 690 days SG. The indication for intervention was similar
etween groups (49% vs 68% claudication; P  .15). Baseline patient
haracteristics were similar between groups, with the exception of more
ransAtlantic Inter-Society Consensus (TASC) D lesions (9 of 67 vs 26 of
0, P  .01) and chronic total occlusion (18 of 67 vs 35 of 60; P  .01) in
he SG group. Freedom from reintervention of the index procedure was
ore likely with SG (28 of 67 vs 40 of 60, P  .01). For both groups, the
ndications for reintervention of the index procedure were prompted by
hanges in symptoms or physical examination findings rather than by abnor-
al findings on surveillance ultrasound imaging (9 of 39 vs 3 of 20). Only
atients in the SG group presented with acute limb ischemia (0 vs 6, P 
01); however, the major adverse limb event rate was not different between
roups (11 vs 10, P .9). The 127 limbs needed 96 primary and secondary
nterventions during the course of the study. Including both primary and
econdary interventions, only patients treated with SG presented with acute
imb ischemia (0 vs 11, P  .1).
Conclusions: Reinterventions are common in both groups; however,
G failure is more likely to present with acute limb ischemia than BMS
ailure. These observations should be carefully considered when treating
POD with BMS or SG.
urgical Treatment of Lower Extremity Venous Aneurysms
rant T. Fankhauser, MD,1 William M. Stone, MD,1 Richard J. Fowl, MD,1
anju Kalra, MBBS,2 Peter Gloviczki, MD,2 W. Andrew Oldenburg, MD,3
nd Samuel R. Money, MD1. 1Division of Vascular Surgery, Mayo Clinic
rizona, Phoenix, Ariz; 2Mayo Clinic, Rochester, Minn; and 3Mayo Clinic
lorida, Jacksonville, Fla
Objective: Lower extremity venous aneurysms are rare. Their symp-
oms, diagnosis, and treatment are varied. The purpose of this study was to
eview our contemporary experience in managing these unusual entities and
efine the treatment options.
Methods: A retrospective review from 1994 to 2011 was conducted at
hree geographically separate institutions. Basic demographics, diagnostic
orkup, treatment, and follow-up were reviewed.
Results: The review included 14 patients with lower extremity venous
neurysms. There were four male patients (29%) and 10 female patients
71%), with a mean age of 46 years (range 14-74 years). The 14 aneurysms
onsisted of seven popliteal vein (50%), three great saphenous vein (21%),
wo small saphenous vein (14%), one common femoral vein (FV) (7%), and
ne FV (7%). Symptoms that led to the diagnosis were pain (n  6, 43%),
eep vein thrombosis (DVT; n  4, 29%), palpable mass (n  2, 14%),
neurysm rupture (n  1, 7%), and knee injury (n  1, 7%). Inferior vena
ava filters were placed preoperatively in two patients with pulmonary
mbolism from popliteal DVT. The five patients with great/small saphenous
ein aneurysms underwent excision. The 10 patients with popliteal, FV, or
ommon FV aneurysms underwent aneurysmectomy with venorrhaphy (n
), aneurysmectomy with interposition saphenous vein graft (n  4), or
neurysm excision with end-to-side anastomosis to the great saphenous vein
Fig.FV, n  1). Surgical complications included three (21%) hematomas
equiring surgical evacuation, two (14%) postoperative thromboses requir-
